Re: The final events.....
|
3
|
Resverlogix Corp.
|
Jan 26, 2019 04:21PM
|
Re: Apabetalone......a Calculated Risk
|
3
|
Resverlogix Corp.
|
Apr 06, 2019 03:21PM
|
Re: Options
|
3
|
Resverlogix Corp.
|
Oct 23, 2019 01:53AM
|
Re: Pfizer's plans for research: sounds like RVX!
|
3
|
Resverlogix Corp.
|
Jan 29, 2020 04:29PM
|
Re: Zacks SCR Report 6/14/17
|
3
|
Resverlogix Corp.
|
Jun 16, 2017 02:47AM
|
Re: Three Nature Medicine Articles on BET inhibitors and Prostate Cancer
|
3
|
Zenith Epigenetics
|
Aug 17, 2017 02:43AM
|
Re: Recent publications:
|
3
|
Resverlogix Corp.
|
Sep 27, 2023 03:28PM
|
Re: Setting expectations....
|
3
|
Resverlogix Corp.
|
Jun 22, 2018 12:43PM
|
Re: What kind of info should we expect from the SSA?
|
3
|
Resverlogix Corp.
|
Apr 22, 2018 12:19PM
|
Re: Feb. 06, 2019 FMV ZENE!
|
3
|
Zenith Epigenetics
|
Feb 07, 2019 05:50PM
|
Re: La vie en rose.....
|
3
|
Resverlogix Corp.
|
Sep 15, 2017 02:52PM
|
Re: Support at the $1.30 area holding strong....
|
3
|
Resverlogix Corp.
|
Nov 18, 2017 07:35PM
|
Re: Re NR
|
3
|
Resverlogix Corp.
|
Apr 14, 2021 02:56PM
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Aug 07, 2020 04:13PM
|
Re: BETonMACE Placebo Estimate
|
3
|
Resverlogix Corp.
|
Feb 20, 2019 12:59PM
|
Re: Biogen/Eisai Scrap Aducanumab
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 03:37PM
|
Re: New Share Price Contest
|
3
|
Resverlogix Corp.
|
Oct 11, 2019 03:57PM
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
3
|
Zenith Epigenetics
|
Sep 03, 2018 11:22PM
|
Re: Why news has to come out Thursday imo....walking in the enemy's shoes
|
3
|
Resverlogix Corp.
|
Jan 29, 2019 02:15PM
|
Re: Another article. Mechanism related.
|
3
|
Resverlogix Corp.
|
Jun 13, 2022 09:06PM
|